Peer-reviewed veterinary case report
Long-term survival with myelodysplastic syndrome in a dog
By Miyamoto, T et al.·Published in Journal of the American Animal Hospital Association·1999·Department of Veterinary Medicine, Japan·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Long-term case study of myelodysplastic syndrome in a dog.
- Species:
- dog
Plain-English summary
A 10-year-old female shih tzu was diagnosed with myelodysplastic syndrome (a blood disorder causing anemia) after showing signs of low red blood cell counts. The vet treated her with a low dose of aclarubicin, a medication used to help improve blood cell production. After starting treatment, the dog's blood counts improved, and she lived for over two years following her diagnosis.
People also search for: dog anemia treatment · shih tzu blood disorder · myelodysplastic syndrome in dogs
Abstract
A 10-year-old, female shih tzu was diagnosed as having myelodysplastic syndrome (MDS) based on the presence of a nonregenerative anemia, dysplastic changes in the three hematopoietic cell lines, a normal to hypercellular bone marrow, and less than 30% blast cells of all nucleated cells in the bone marrow. Low-dose aclarubicin, a differentiation-induction therapy for MDS and atypical leukemias in humans, was administered. Hematological improvement was observed, and the dog lived for 809 days after the first presentation.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/10580906/